Liquid Biopsy Market Growth is Expected to Account for 18.9% CAGR to Gain USD 15.2 Billion by 2032

Liquid Biopsy Market Research Report Information By Biomarker Types (Circulating Tumor Cells, Circulating Tumor DNA, Extracellular Vesicles, and Other Biomarker), By Application (Cancer Therapeutic Application, Reproductive Health, and Other Therapeutic), By Sample (Blood Sample, Urine Sample, and Other), And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) – Market Forecast Till 2032

The global liquid biopsy market is expected to grow from USD 3.81 billion in 2022 to USD 15.2 billion by 2032, at a CAGR of 18.9% during the forecast period. Liquid biopsy is a non-invasive medical procedure that uses blood samples to detect cancer cells or cancer-related genetic material (DNA or RNA). It is a relatively new technology, but it has the potential to revolutionize cancer diagnosis and treatment.

Patients and healthcare providers are increasingly preferring non-invasive diagnostic procedures over traditional invasive procedures, such as biopsies. Liquid biopsy is a non-invasive procedure that can be performed with a simple blood draw.

Cancer is one of the leading causes of death worldwide, and its incidence is expected to continue to rise in the coming years. Liquid biopsy can be used to detect cancer at an early stage, when it is most treatable.

Get Free Sample PDF Brochure @ https://www.marketresearchfuture.com/sample_request/710

Competitive Outlook

Some of the Key Players of liquid biopsy market includes Hoffmann-La Roche Ltd. (Switzerland), Myriad Genetics, Inc. (US), QIAGEN (Netherlands), Thermo Fisher Scientific, Inc. (US), Guardant Health, Inc. (US), MDxHealth SA (Belgium), Exact Sciences Corporation (US), Illumina Inc. (US), Sysmex Inostics (US), Biocept, Inc. (US), NeoGenomics, Inc. (US), ANGLE plc (UK), Menarini-Silicon Biosystems (Italy), Vortex Biosciences, Inc. (US), Exosome Diagnostics, Inc. (US), Agena Bioscience, Inc. (US), MedGenome Inc. (US), Epigenomics AG (Germany), Personal Genome Diagnostics, Inc. (US)

Segmentation:

Global liquid biopsy market has been segmented on the basis of biomarker type which comprises of circulating tumor cells (Ctcs), circulating tumor DNA (Ctdna), extracellular vesicles (Evs) and other biomarker.

On the basis of application; market is segmented into cancer therapeutic application, reproductive health, and other therapeutic application.

On the basis of sample; market is segmented into blood, urine and others.

On the basis of end-users; market is segmented into hospitals and laboratories, academic and research centres and others.

Browse In-depth Market Research Report (171 Pages) on Liquid Biopsy: https://www.marketresearchfuture.com/reports/liquid-biopsy-market-710

Regional Analysis

Depending on geographic region, Liquid biopsy market is segmented into four key regions: Americas, Europe, Asia Pacific, and Middle East & Africa. Globally developed countries led by North America is the largest market for Liquid biopsy. Europe is the second-largest market for liquid biopsy. The developing regions market such as Asia pacific region and Middle East & Africa however is rising much faster.

Discover More Research Reports on Healthcare Industry by Market Research Future:

Companion Diagnostics for Oncology Market Research Report Information By Products & Services (Assays, Kits & Reagents and Software & Services), Technology (Polymerase Chain Reaction (PCR) and Next-Generation Sequencing (NGS), Indication (Lung Cancer, Breast Cancer, Colorectal Cancer, Gastric Cancer, Melanoma), End User (Pharmaceutical & Biopharmaceutical Companies, Contract Research Organizations, Laboratories) – Forecast till 2032

Anti-Fungal Treatment Market Research Report Information by Drug Class (Azoles, Echinocandins, Polyenes, Allylamines, Pyrimidines), Therapeutic Indication (Systemic, Candidiasis, Cryptococcosis, Prophylactic Use of Antifungals, Coccidioidomycosis), Pathogen (Candid, Aspergillus, Cryptococcus, CoccidiodiesImmitis, Zygomycetes, Trichophyton), End Users (Hospitals & Clinics, Dermatology Clinics) and Region (Americas, Europe, Asia-Pacific, and Middle East & Africa) – Forecast till 2032

Anticoagulation Market Research Report Information by Drug Class (Novel and Direct Anticoagulants [DOACs], Heparin and Low Molecular Weight [LMWH], Warfarin, Vitamin K Antagonists), Disease Indication(Anti Fibrillation [A-Fib], Stroke, Deep Vein Thrombosis/Pulmonary Embolism [PE], Mechanical Heart Valves [MHV]), Route of Administration (Oral and Injectable), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and Region (North America, Europe, Asia-Pacific, and Rest of the World)—Forecast till 2030

About Market Research Future:

Market Research Future (MRFR) is a global market research company that takes pride in its services, offering a complete and accurate analysis with regard to diverse markets and consumers worldwide. Market Research Future has the distinguished objective of providing the optimal quality research and granular research to clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help answer your most important questions.

Follow Us: LinkedIn | Twitter

Contact:

Market Research Future (Part of Wantstats Research and Media Private Limited)

99 Hudson Street, 5Th Floor

New York, NY 10013

United States of America

+1 628 258 0071 (US)

+44 2035 002 764 (UK)

Email: sales@marketresearchfuture.com

Website: https://www.marketresearchfuture.com

Tags: Liquid Biopsy Market, Liquid Biopsy Market Share, Liquid Biopsy Market Growth, Liquid Biopsy Market Size, Liquid Biopsy market trends, Liquid Biopsy Market Outlook, Liquid Biopsy Market Overview, Liquid Biopsy Market Report, Liquid Biopsy Market Research, Liquid Biopsy Market Insights, Liquid Biopsy Market Players See Campaign: https://www.marketresearchfuture.com/reports/liquid-biopsy-market-710

Contact Information:

Market Research Future (Part of Wantstats Research and Media Private Limited) 99 Hudson Street, 5Th Floor New York, NY 10013 United States of America +1 628 258 0071 (US) +44 2035 002 764 (UK) Email: sales@marketresearchfuture.com Website: https://www.marketresearchfuture.com

Tags:
Research Newswire, English